{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04247945",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSC-SCT-03"
      },
      "Organization": {
        "OrgFullName": "Fujian Medical University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Co-transplantation of MSC in the Setting of Allo-HSCT",
      "OfficialTitle": "Co-transplantation of Mesenchymal Stromal Cells in Allogeneic Hematopoietic Stem Cell Transplantation"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 1, 2020",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 1, 2023",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 1, 2025",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "January 28, 2020",
      "StudyFirstSubmitQCDate": "January 29, 2020",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 30, 2020",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 29, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 30, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Ting YANG",
        "ResponsiblePartyInvestigatorTitle": "Professor of Hematology",
        "ResponsiblePartyInvestigatorAffiliation": "Fujian Medical University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Fujian Medical University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Mesenchymal stem cells (MSCs) are known to exhibit immunomodulatory, anti-inflammatory, and pro-angiogenic properties, and therefore have the potential to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) .The study is aimed to identify and evaluate the potential benefits of MSCs infusion during allogeneic HSCT, with regard to the engraftment, graft versus host disease (GVHD), post-transplant relapse and survival."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Allogeneic Hematopoietic Stem Cell Transplantation"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2",
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Prevention",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "120",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "HSC",
            "ArmGroupType": "No Intervention"
          },
          {
            "ArmGroupLabel": "MSC+HSC",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Cotransplant with MSCs"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Cotransplant with MSCs",
            "InterventionDescription": "Co-transplantation of MSCs during allogeneic HSCT",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSC+HSC"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Survival Rate",
            "PrimaryOutcomeTimeFrame": "up to 2 years after HSCT"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Cumulative Incidence of Graft-versus Host Disease",
            "SecondaryOutcomeTimeFrame": "up to 2 years after HSCT"
          },
          {
            "SecondaryOutcomeMeasure": "Incidence of Systemic Infections",
            "SecondaryOutcomeTimeFrame": "up to 2 years after HSCT"
          },
          {
            "SecondaryOutcomeMeasure": "Mean Time to Engraftment",
            "SecondaryOutcomeTimeFrame": "Baseline to engraftment, assessed minimally 28 days post transplant"
          },
          {
            "SecondaryOutcomeMeasure": "Transplant-Related Mortality",
            "SecondaryOutcomeTimeFrame": "up to 1 months after HSCT"
          },
          {
            "SecondaryOutcomeMeasure": "Rates of Relapse",
            "SecondaryOutcomeTimeFrame": "up to 2 years after HSCT"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSigned written informed consent\nAged <65 years\nWilling to transplant\nCardiac: Left ventricular ejection fraction ≥ 50%\nAdequate renal and hepatic function\nPerformance status: Karnofsky ≥ 70%\n\nExclusion Criteria:\n\nPregnant or lactating females.\nAny co-morbidity precluding the administration of MSCs.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Ting Yang, Prof.",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+86-591-86218041",
            "CentralContactEMail": "yang.hopeting@gmail.com"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Union Hospital,Fujian Medical University",
            "LocationStatus": "Recruiting",
            "LocationCity": "Fuzhou",
            "LocationState": "Fujian",
            "LocationZip": "350001",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Ting Yang, Prof.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+86-591-86218041",
                  "LocationContactEMail": "yang.hopeting@gmail.com"
                },
                {
                  "LocationContactName": "Jianda Hu, Prof.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+86-591-86218041",
                  "LocationContactEMail": "jdhu@medmail.com.cn"
                },
                {
                  "LocationContactName": "Ting Yang, Dr.",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    }
  }
}